CUSIP 30233G209COM NEWEYPTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
163 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 8.27M | $151.00M | −60.0K | Reduced |
| 2 | Suvretta Capital Management, LLC | 7.83M | $143.01M | +1.63M | Added |
| 3 | Blackrock, Inc. | 6.79M | $124.01M | +1.82M | Added |
| 4 | Federated Hermes, Inc. | 6.02M | $109.94M |
| +1.60M |
| Added |
| 5 | Franklin Resources Inc | 4.98M | $90.93M | +805.0K | Added |
| 6 | Vanguard Group Inc | 4.82M | $88.10M | +1.03M | Added |
| 7 | Adage Capital Partners Gp, L.L.C. | 4.70M | $85.87M | −859.8K | Reduced |
| 8 | Paradigm Biocapital Advisors LP | 3.69M | $67.44M | +1.69M | Added |
| 9 | Tcg Crossover Management, LLC | 3.57M | $65.27M | 0 | Held |
| 10 | Janus Henderson Group PLC | 2.94M | $53.66M | +2.94M | New |
See every fund holding Eyepoint Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders